DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,535.00
-100.00 (-2.75%)
At close: Jan 30, 2026
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 113.06 billion as of January 30, 2026.
Market Cap
113.06B
Enterprise Value
143.39B
Revenue
131.17B
Ranking
n/a
PE Ratio
9.32
Stock Price
3,535.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 113.06B, a decrease of -43.58%. That is a compound annual growth rate of -45.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 116.26B | -0.68% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.78T |
| Celltrion | 45.95T |
| ALTEOGEN | 22.09T |
| Sam Chun Dang Pharm. | 11.18T |
| Shinhung | 127.78B |
| Jeil Pharma Holdings | 123.58B |
| iNtRON Biotechnology | 121.24B |
| CKD Bio | 117.67B |